KeyBank National Association’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-3,496
| Closed | -$859K | – | 1101 |
|
|
2022
Q3 | $859K | Buy |
3,496
+399
| +13% | +$108K | ﹤0.01% | 481 |
|
|
2022
Q2 | $767K | Buy |
3,097
+34
| +1% | +$9.18K | ﹤0.01% | 525 |
|
|
2022
Q1 | $1.01M | Sell |
3,063
-2,283
| -43% | -$703K | ﹤0.01% | 505 |
|
|
2021
Q4 | $1.92M | Buy |
5,346
+1,830
| +52% | +$618K | 0.01% | 408 |
|
|
2021
Q3 | $1.15M | Buy |
3,516
+622
| +21% | +$211K | 0.01% | 515 |
|
|
2021
Q2 | $903K | Sell |
2,894
-948
| -25% | -$291K | ﹤0.01% | 590 |
|
|
2021
Q1 | $1.23M | Buy |
3,842
+352
| +10% | +$113K | 0.01% | 504 |
|
|
2020
Q4 | $1.13M | Sell |
3,490
-70
| -2% | -$19.4K | 0.01% | 490 |
|
|
2020
Q3 | $986K | Sell |
3,560
-1,156
| -25% | -$333K | 0.01% | 484 |
|
|
2020
Q2 | $1.14M | Buy |
+4,716
| New | +$947K | 0.01% | 426 |
|
|
2019
Q4 | – | Sell |
-5,026
| Closed | -$894K | – | 1038 |
|
|
2019
Q3 | $894K | Sell |
5,026
-3,088
| -38% | -$668K | 0.01% | 535 |
|
|
2019
Q2 | $2.11M | Buy |
8,114
+3,222
| +66% | +$855K | 0.01% | 356 |
|
|
2019
Q1 | $1.4M | Buy |
4,892
+579
| +13% | +$192K | 0.01% | 427 |
|
|
2018
Q4 | $1.4M | Sell |
4,313
-1,320
| -23% | -$459K | 0.01% | 407 |
|
|
2018
Q3 | $2.53M | Sell |
5,633
-9,284
| -62% | -$3.66M | 0.01% | 317 |
|
|
2018
Q2 | $6.1M | Sell |
14,917
-1,197
| -7% | -$434K | 0.04% | 233 |
|
|
2018
Q1 | $4.69M | Sell |
16,114
-6,286
| -28% | -$1.59M | 0.03% | 262 |
|
|
2017
Q4 | $4.2M | Sell |
22,400
-5,275
| -19% | -$985K | 0.02% | 265 |
|
|
2017
Q3 | $4.67M | Sell |
27,675
-1,343
| -5% | -$203K | 0.03% | 258 |
|
|
2017
Q2 | $4.16M | Buy |
29,018
+1,884
| +7% | +$253K | 0.02% | 266 |
|
|
2017
Q1 | $3.4M | Buy |
27,134
+2,381
| +10% | +$276K | 0.02% | 291 |
|
|
2016
Q4 | $2.79M | Buy |
24,753
+2,963
| +14% | +$343K | 0.02% | 314 |
|
|
2016
Q3 | $2.8M | Buy |
21,790
+9,470
| +77% | +$1.13M | 0.02% | 309 |
|
|
2016
Q2 | $1.35M | Sell |
12,320
-3,002
| -20% | -$299K | 0.01% | 438 |
|
|
2016
Q1 | $1.45M | Buy |
15,322
+1,624
| +12% | +$137K | 0.01% | 428 |
|
|
2015
Q4 | $1.24M | Buy |
13,698
+5,050
| +58% | +$429K | 0.01% | 497 |
|
|
2015
Q3 | $802K | Buy |
+8,648
| New | +$762K | 0.01% | 646 |
|
Other funds holding ABMD
TRSOTSOK
BTI
IA
AW
HNB
KeyBank National Association's ABMD Position: Q4 2022 in Review
KeyBank National Association sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 3,496 shares — an estimated $859K sold.
KeyBank National Association first reported a position in ABMD in Q3 2015 and held it in 27 quarters. The position peaked at $6.1M in Q2 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.
- KeyBank National Association reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
- KeyBank National Association sold 3,496 Abiomed Inc shares in Q4 2022, an estimated $859K.
- KeyBank National Association first reported a position in Abiomed Inc in Q3 2015 and held it in 27 quarters.
- KeyBank National Association's Abiomed Inc position peaked at $6.1M in Q2 2018.
- 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.
Based on KeyBank National Association's 13F filing for Q4 2022, filed 31 Jan 2023.